Diabetic Nephropathy Epidemiology Forecast 2024-2032

Diabetic Nephropathy Epidemiology Forecast Report Coverage

Expert Market Research's “Diabetic Nephropathy Epidemiology Forecast Report 2024-2032” offers comprehensive information on the prevalence and demographics of diabetic nephropathy. It projects the future incidence and prevalence rates of diabetic nephropathy across various populations. The study covers age and type as major determinants of the diabetic nephropathy-affected population. The report highlights patterns in the prevalence of diabetic nephropathy over time and projects future trends based on multiple variables.

Diabetic Nephropathy: Disease Overview

Diabetic nephropathy, a common complication of type 1 and type 2 diabetes, causes the kidneys to gradually lose function. High blood sugar levels in diabetes patients often damage the blood vessels in the kidneys, subsequently leading to kidney damage. Common symptoms include swelling in the face, foamy urine, tiredness, loss of appetite, and muscle cramps, among others. There are five stages of diabetic nephropathy, with the fifth stage being end-stage renal disease (ESRD).

Diabetic Nephropathy: Treatment Overview

To slow the progression of diabetic nephropathy, lowering blood pressure and maintaining blood sugar control are extremely essential. Insulin, metformin, and SGLT2 inhibitors are the common medications that are used to control blood sugar. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin 2 receptor blockers (ARBs) are also widely prescribed for treating high blood pressure in the affected patients. Dialysis or a kidney transplant are typically the treatment options for patients whose diabetic nephropathy progresses to end-stage renal disease.

Epidemiology

The diabetic nephropathy epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for diabetic nephropathy by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for diabetic nephropathy and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• Research indicates that the incidence of diabetic nephropathy rises as the prevalence of diabetes increases, with around 30% to 40% of diabetes mellitus patients reported to develop diabetic nephropathy.
• According to a research article published in the Journal of Nutrition and Metabolism (2021), 36% of people with diabetes in the United States and 25% of people with diabetes in the United Kingdom are estimated to have diabetic nephropathy.
• As per a retrospective cohort study by Zhang, Fan et al. (2024), women carry a higher risk of developing diabetic nephropathy as well as a faster decline in renal function in comparison to men.
• Studies show that the peak incidence (3%/year) is generally found in individuals who have had diabetes for around 10 to 20 years. Also, the mean age of diabetic patients who develop end-stage kidney disease is approximately 60 years.

Country-wise Diabetic Nephropathy Epidemiology

The diabetic nephropathy epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of diabetic nephropathy differs between countries owing to factors such as the prevalence of diabetes, genetic predisposition, lifestyle patterns, and public health policies, among others. Studies reveal that around 1 in 3 people suffering from diabetes have diabetic nephropathy as a complication in the United States.

Country Specific Stats:

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of diabetic nephropathy based on several factors.
• Diabetic Nephropathy Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of diabetic nephropathy are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of diabetic nephropathy epidemiology in the 8 major markets?
• What will be the total number of patients with diabetic nephropathy across the 8 major markets during the forecast period?
• What was the country-wise prevalence of diabetic nephropathy in the 8 major markets in the historical period?
• Which country will have the highest number of diabetic nephropathy patients during the forecast period of 2024-2032?
• Which key factors would influence the shift in the patient population of diabetic nephropathy during the forecast period of 2024-2032?
• What are the currently available treatments for diabetic nephropathy?
• What are the disease risks, signs, symptoms, and unmet needs of diabetic nephropathy?

Related Reports

Global Diabetes Drugs Market

Type 1 Diabetes Market